Japanese Big Pharma Eisai is teaming up with Boston-based digital health company Linus Health to create new “Brain Health Reports.”
Timed to coincide with National Alzheimer's Disease Awareness Month in November, the newly launched ExploreYourBrainHealth.com works to test adults’ “thinking activities, lifestyle factors and personal priorities,” according to a release.
The results of these questions are then put into a Brain Health Report that can help assess someone’s overall brain health. This could also potentially point them toward any higher risks of conditions like Alzheimer’s Disease (AD), although the company makes no direct medical links or diagnoses.
Worth noting, the reports are only designed to only be “educational," according to Eisai, which adds that “participants may choose to share their Brain Health Report with a healthcare provider to discuss any concerns about their brain health.” The report also comes with “links to third-party resources.”
Eisai has for many years developed and sold AD therapies including Aricept and, more recently, Leqembi, which was co-developed with Biogen.
“Brain health is deeply personal, and people deserve approachable ways to better understand the factors that may impact it,” said Tory Burgio, VP, U.S. Neurology Commercial, Eisai, in a statement.
“Through our support of ExploreYourBrainHealth.com, we're making it easier to explore brain health in a way that reflects individual priorities and provides practical resources that can support informed conversations with family members and health care providers.”